These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

616 related articles for article (PubMed ID: 25232854)

  • 21. Exome sequencing covers >98% of mutations identified on targeted next generation sequencing panels.
    LaDuca H; Farwell KD; Vuong H; Lu HM; Mu W; Shahmirzadi L; Tang S; Chen J; Bhide S; Chao EC
    PLoS One; 2017; 12(2):e0170843. PubMed ID: 28152038
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Disease-targeted sequencing: a cornerstone in the clinic.
    Rehm HL
    Nat Rev Genet; 2013 Apr; 14(4):295-300. PubMed ID: 23478348
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A post-hoc comparison of the utility of sanger sequencing and exome sequencing for the diagnosis of heterogeneous diseases.
    Neveling K; Feenstra I; Gilissen C; Hoefsloot LH; Kamsteeg EJ; Mensenkamp AR; Rodenburg RJ; Yntema HG; Spruijt L; Vermeer S; Rinne T; van Gassen KL; Bodmer D; Lugtenberg D; de Reuver R; Buijsman W; Derks RC; Wieskamp N; van den Heuvel B; Ligtenberg MJ; Kremer H; Koolen DA; van de Warrenburg BP; Cremers FP; Marcelis CL; Smeitink JA; Wortmann SB; van Zelst-Stams WA; Veltman JA; Brunner HG; Scheffer H; Nelen MR
    Hum Mutat; 2013 Dec; 34(12):1721-6. PubMed ID: 24123792
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Analysis and annotation of whole-genome or whole-exome sequencing-derived variants for clinical diagnosis.
    Worthey EA
    Curr Protoc Hum Genet; 2013 Oct; 79():9.24.1-9.24.24. PubMed ID: 24510652
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Precision medicine for cancer with next-generation functional diagnostics.
    Friedman AA; Letai A; Fisher DE; Flaherty KT
    Nat Rev Cancer; 2015 Dec; 15(12):747-56. PubMed ID: 26536825
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Human Mutation special issue on innovations in genomic diagnostics.
    Scott SA; Wang K; Spinner NB
    Hum Mutat; 2022 Nov; 43(11):1493-1494. PubMed ID: 36116036
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Development and Validation of Clinical Whole-Exome and Whole-Genome Sequencing for Detection of Germline Variants in Inherited Disease.
    Hegde M; Santani A; Mao R; Ferreira-Gonzalez A; Weck KE; Voelkerding KV
    Arch Pathol Lab Med; 2017 Jun; 141(6):798-805. PubMed ID: 28362156
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical sequencing: From raw data to diagnosis with lifetime value.
    Caspar SM; Dubacher N; Kopps AM; Meienberg J; Henggeler C; Matyas G
    Clin Genet; 2018 Mar; 93(3):508-519. PubMed ID: 29206278
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Orthogonal NGS for High Throughput Clinical Diagnostics.
    Chennagiri N; White EJ; Frieden A; Lopez E; Lieber DS; Nikiforov A; Ross T; Batorsky R; Hansen S; Lip V; Luquette LJ; Mauceli E; Margulies D; Milos PM; Napolitano N; Nizzari MM; Yu T; Thompson JF
    Sci Rep; 2016 Apr; 6():24650. PubMed ID: 27090146
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Targeted next-generation sequencing panels for monogenetic disorders in clinical diagnostics: the opportunities and challenges.
    de Koning TJ; Jongbloed JD; Sikkema-Raddatz B; Sinke RJ
    Expert Rev Mol Diagn; 2015 Jan; 15(1):61-70. PubMed ID: 25367078
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Applications of targeted gene capture and next-generation sequencing technologies in studies of human deafness and other genetic disabilities.
    Lin X; Tang W; Ahmad S; Lu J; Colby CC; Zhu J; Yu Q
    Hear Res; 2012 Jun; 288(1-2):67-76. PubMed ID: 22269275
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical exome sequencing in neurogenetic and neuropsychiatric disorders.
    Fogel BL; Lee H; Strom SP; Deignan JL; Nelson SF
    Ann N Y Acad Sci; 2016 Feb; 1366(1):49-60. PubMed ID: 26250888
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Exome versus transcriptome sequencing in identifying coding region variants.
    Ku CS; Wu M; Cooper DN; Naidoo N; Pawitan Y; Pang B; Iacopetta B; Soong R
    Expert Rev Mol Diagn; 2012 Apr; 12(3):241-51. PubMed ID: 22468815
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Imputation-based assessment of next generation rare exome variant arrays.
    Martin AR; Tse G; Bustamante CD; Kenny EE
    Pac Symp Biocomput; 2014; ():241-52. PubMed ID: 24297551
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Exome sequencing explained: a practical guide to its clinical application.
    Seaby EG; Pengelly RJ; Ennis S
    Brief Funct Genomics; 2016 Sep; 15(5):374-84. PubMed ID: 26654982
    [TBL] [Abstract][Full Text] [Related]  

  • 36. MoBiDiC Prioritization Algorithm, a Free, Accessible, and Efficient Pipeline for Single-Nucleotide Variant Annotation and Prioritization for Next-Generation Sequencing Routine Molecular Diagnosis.
    Yauy K; Baux D; Pegeot H; Van Goethem C; Mathieu C; Guignard T; Juntas Morales R; Lacourt D; Krahn M; Lehtokari VL; Bonne G; Tuffery-Giraud S; Koenig M; Cossée M
    J Mol Diagn; 2018 Jul; 20(4):465-473. PubMed ID: 29689380
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical sequencing: is WGS the better WES?
    Meienberg J; Bruggmann R; Oexle K; Matyas G
    Hum Genet; 2016 Mar; 135(3):359-62. PubMed ID: 26742503
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Application of advanced molecular technology in the diagnosis and management of genetic disorders in South Africa.
    Kotze M
    S Afr Med J; 2016 May; 106(6 Suppl 1):S114-8. PubMed ID: 27245544
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Experience of a multidisciplinary task force with exome sequencing for Mendelian disorders.
    Fokstuen S; Makrythanasis P; Hammar E; Guipponi M; Ranza E; Varvagiannis K; Santoni FA; Albarca-Aguilera M; Poleggi ME; Couchepin F; Brockmann C; Mauron A; Hurst SA; Moret C; Gehrig C; Vannier A; Bevillard J; Araud T; Gimelli S; Stathaki E; Paoloni-Giacobino A; Bottani A; Sloan-Béna F; Sizonenko LD; Mostafavi M; Hamamy H; Nouspikel T; Blouin JL; Antonarakis SE
    Hum Genomics; 2016 Jun; 10(1):24. PubMed ID: 27353043
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Exploiting the potential of next-generation sequencing in genomic medicine.
    Pinto AM; Ariani F; Bianciardi L; Daga S; Renieri A
    Expert Rev Mol Diagn; 2016 Sep; 16(9):1037-47. PubMed ID: 27574853
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 31.